AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2014
Sep 26, 2014
33153_dirs_2014-09-26_01267a8b-ac73-4a11-b2fc-9ac21ac3669a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO (MLAB)
CIK: 0000724004
Period of Report: 2014-09-23
Reporting Person: Sullivan John James (President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-23 | Common Stock | M | 6000 | $15.44 | Acquired | 41999 | Direct |
| 2014-09-23 | Common Stock | M | 8000 | $18.98 | Acquired | 49999 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-23 | Non-Qualified Stock Option | $15.44 | X | 6000 | Disposed | 2016-03-20 | Common Stock (6000) | Direct |
| 2014-09-23 | Non-Qualified Stock Option | $18.98 | X | 8000 | Disposed | 2017-05-11 | Common Stock (8000) | Direct |
Footnotes
F1: 4000 Shares exercisable on 5/ 11/2008 and 4000 exercisable on 5/11/2009
F2: 3000 Shares exercisable on 3/20/2011 and 7500 exercisable on 3/20/2012
More from MESA LABORATORIES INC /CO/
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6